Evidence map›Paper›PMID 42137504›Full record

ArticleFrontiers in nuclear medicine2026

Radiopharmacy services in South African academic hospitals: implications for planning radiopharmacy services in Africa.

David Kimani, Beverley Summers, Lerato Mosima

Abstract read
In one paragraph

Article in Frontiers in nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David KimaniDepartment of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Beverley SummersDepartment of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Lerato MosimaDepartment of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Nuclear medicine (NM) is being embraced by undeveloped countries as a specialty. Due to the high costs involved in establishing new NM and radiopharmacy centres, proper planning is essential. This study describes the pattern of radiopharmacy services and staffing in NM departments in South African Academic hospitals (SAAHs); which can aid planning of new NM and radiopharmacy centres in similar settings. Methods: The study was retrospective, descriptive, and quantitative. An anonymized questionnaire was sent via Survey Monkey® to the nine SAAHs to determine nuclear medicine patient numbers by scan type, identify cameras, equipment, staffing levels, commonly used radiopharmaceuticals, and define the basic requirements for establishing new facilities. Results: The response rate was 78% (7/9 hospitals). Average number of NM patients seen per hospital was 7,040 for 2022. All hospitals had SPECT-CT cameras; six had PET-CT cameras and one referred PET patients to a private hospital. All hospitals had NM physicians (range 2-13, average 5) and at least one medical physicist (range 1-4). Only two hospitals had radiopharmacists (only one in each). Conclusion: To promote optimal patient services and support research in SAAHs, norms must be developed that are applicable to Africa. Appropriate staff quotas and equipment are required for the African setting to promote optimal use of radiopharmaceuticals and enable NMs to operate to their full potential. Key things to help in planning and establishing new radiopharmacy centers include; adopting centralized radiopharmaceutical production and aligning staffing with international guidelines.

Indexed as

nuclear medicinePET-CTradiopharmaceuticalsradiopharmacySPECT-CTstaffing norms

Identifiers

PMID42137504
PMCPMC13167944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.